366 related articles for article (PubMed ID: 24872596)
1. Personal utility in genomic testing: is there such a thing?
Bunnik EM; Janssens AC; Schermer MH
J Med Ethics; 2015 Apr; 41(4):322-6. PubMed ID: 24872596
[TBL] [Abstract][Full Text] [Related]
2. Personal utility is inherent to direct-to-consumer genomic testing.
Chung MW; Ng JC
J Med Ethics; 2016 Oct; 42(10):649-52. PubMed ID: 27250638
[TBL] [Abstract][Full Text] [Related]
3. A closer look revisited: are we subjects or are we donors?
Fisher R
Genet Med; 2012 Apr; 14(4):458-60. PubMed ID: 22361901
[TBL] [Abstract][Full Text] [Related]
4. Direct to consumer genetic testing and the libertarian right to test.
Loi M
J Med Ethics; 2016 Sep; 42(9):574-7. PubMed ID: 27009980
[TBL] [Abstract][Full Text] [Related]
5. Disclosing individual genetic results to research participants.
Ravitsky V; Wilfond BS
Am J Bioeth; 2006; 6(6):8-17. PubMed ID: 17085395
[TBL] [Abstract][Full Text] [Related]
6. Tiered disclosure options promote the autonomy and well-being of research subjects.
Rothstein MA
Am J Bioeth; 2006; 6(6):20-1; author reply W10-2. PubMed ID: 17085397
[No Abstract] [Full Text] [Related]
7. Ethical considerations in the communication of unexpected information with clinical implications.
Lavieri RR; Garner SA
Am J Bioeth; 2006; 6(6):46-8; author reply W10-2. PubMed ID: 17085410
[No Abstract] [Full Text] [Related]
8. Direct-to-consumer personal genome testing and cancer risk prediction.
Bellcross CA; Page PZ; Meaney-Delman D
Cancer J; 2012; 18(4):293-302. PubMed ID: 22846729
[TBL] [Abstract][Full Text] [Related]
9. Personal genome testing: test characteristics to clarify the discourse on ethical, legal and societal issues.
Bunnik EM; Schermer MH; Janssens AC
BMC Med Ethics; 2011 Jun; 12():11. PubMed ID: 21672210
[TBL] [Abstract][Full Text] [Related]
10. Feedback of individual genetic results to research participants: in favor of a qualified disclosure policy.
Bredenoord AL; Onland-Moret NC; Van Delden JJ
Hum Mutat; 2011 Aug; 32(8):861-7. PubMed ID: 21538687
[TBL] [Abstract][Full Text] [Related]
11. Undesirable implications of disclosing individual genetic results to research participants.
Meltzer LA
Am J Bioeth; 2006; 6(6):28-30; author reply W10-2. PubMed ID: 17085401
[No Abstract] [Full Text] [Related]
12. Clinical utility and full disclosure of genetic results to research participants.
Sharp RR; Foster MW
Am J Bioeth; 2006; 6(6):42-4; author reply W10-2. PubMed ID: 17085408
[No Abstract] [Full Text] [Related]
13. MSJAMA. Between a rock and a hard place.
Garrison A
JAMA; 2003 Sep; 290(9):1217-8. PubMed ID: 12953008
[No Abstract] [Full Text] [Related]
14. MSJAMA. Genetic information and competing interests.
Ihler E
JAMA; 2003 Sep; 290(9):1216. PubMed ID: 12953007
[No Abstract] [Full Text] [Related]
15. MSJAMA. The dilemma of confidentiality in Huntington disease.
Wusthoff C
JAMA; 2003 Sep; 290(9):1219-20. PubMed ID: 12953009
[No Abstract] [Full Text] [Related]
16. What can we Learn from Patients' Ethical Thinking about the right 'not to know' in Genomics? Lessons from Cancer Genetic Testing for Genetic Counselling.
Cowley L
Bioethics; 2016 Oct; 30(8):628-35. PubMed ID: 27523581
[TBL] [Abstract][Full Text] [Related]
17. Playing a part in research? University students' attitudes to direct-to-consumer genomics.
Vayena E; Ineichen C; Stoupka E; Hafen E
Public Health Genomics; 2014; 17(3):158-68. PubMed ID: 24777115
[TBL] [Abstract][Full Text] [Related]
18. The return of individual research findings in paediatric genetic research.
Hens K; Nys H; Cassiman JJ; Dierickx K
J Med Ethics; 2011 Mar; 37(3):179-83. PubMed ID: 21059631
[TBL] [Abstract][Full Text] [Related]
19. Ethical considerations in the social context of Huntington disease.
Turner D
Dis Markers; 1992; 10(4):171-83; discussion 211-28. PubMed ID: 1304435
[No Abstract] [Full Text] [Related]
20. Naming and framing in genomic testing.
Bunnik EM; Schermer MH; Janssens AC
Trends Mol Med; 2014 Feb; 20(2):63-5. PubMed ID: 24485561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
